Effectiveness of nifedipine compared with other antihypertension on hypertension during pregnancy
Abstract
Hypertension is the most common complication of pregnancy. It is a major cause of maternal, fetal, and neonatal morbidity and mortality. In this article, the effectiveness of nifedipine compared with other antihypertensives in pregnant women with hypertension was reviewed. The randomized control trial (RCT) of nifedipine and other antihypertension in pregnancy without complications published from 2016 to 2021 in Google Scholar, Cochrane and PubMed were gathered. It was reported that antihypertensives administration to pregnant women with hypertension was very meaningful both for the mother herself and for the fetus or baby. Furthermore, nifedipine has better effectiveness in lowering blood pressure compared to other antihypertensives such as IV labetalol, oral labetalol, IV hydralazine, methyldopa in the treatment of preeclampsia, severe preeclampsia, severe pre-eclampsia/eclampsia, chronic hypertension, hypertension emergency, and severe hypertension.
References
PERKI. Guidelines for the management of cardiovascular disease in pregnancy, 1st Edition. Jakarta: Indonesian Association of Cardiovascular Specialists, 2021.
Tinawi M. Hypertension in pregnancy. Arch Intern Med Res 2020; 3(1): 010-7.
http://doi.org/10.26502/aimr.0018
Brown MA, Magee LA, Kenny LC, Karumanchi AS, McCarthy FP, et al. Hypertensive disorders of pregnancy ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018; 72:24-43.
https://doi.org/10.1161/HYPERTENSIONAHA.117.1083
Adebayo JA, Nwafor JI, Lawani LO, Esike CO, Olaleye AA, Adiele NA. Efficacy of nifedipine versus hydralazine in the management of severe hypertension in pregnancy: a randomized controlled trial. Niger Postgrad Med J 2021. 27(4):317-24.
https://doi.org/10.4103/npmj.npmj_275_20
Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomized controlled trial. Lancet 2019; 394(10203):1011-21.
https://doi.org/10.1016/S0140-6736(19)31282-6
Zulfeen M, Tatapudib R, Sowjanya R. IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy–a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2019; 236:46-52.
https://doi.org/10.1016/j.ejogrb.2019.01.022
Webster LM, Myers JE, Piercy CN, Harding K, Cruickshank JK, Coote IW, et al. Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy a randomized controlled trial. Hypertension 2017; 70(5):915-22.
https://doi.org/10.1161/hypertensionaha.117.09972
Salama M, Rezk M, Gabera W, Hamza H, Marawan H, Gamal A, et al. Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: a multicenter randomized clinical trial. Pregnancy Hypertens 2019;17:54-8.
https://doi.org/10.1016/j.preghy.2019.05.009
Shi DD, Yang FZ, Zhou L, Wang N. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia. J Clin Pharm Ther 2016; 41(6):657-61.
http://doi.org/10.1111/jcpt.12439
Thalamati S, Bandaru S, Bhumireddy D. Assessment of safety and efficacy of oral nifedipine and intravenous labetalol in management of increased blood pressure in severe preeclampsia. Int J Reprod Contracept Obstet Gynecol 2018; 7(7):2645-9.
http://doi.org/10.18203/2320-1770.ijrcog20182465
Havle PA and Havle PA. Efficacy of oral labetalol and oral nifedipine in management of hypertensive disorders of pregnancy. J Nat Remed 2020; 21(3):60-3.
Sharma C, Soni A, Gupta A, Verma A, Verma S. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. Am J Obstet Gynecol 2017; 217(6):687.e1-e6.
